Doxofylline SR Tablets Exporter India | Bronchodilator Supplier

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Doxofylline Sustained-Release tablets are bronchodilator formulations designed to provide prolonged relief in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The sustained-release mechanism ensures controlled and extended drug release, helping maintain consistent therapeutic levels and improving breathing function over an extended period.

In international pharmaceutical markets, Doxofylline sustained release tablets exporter India and SR bronchodilator tablet supplier India pharma are widely searched by respiratory medicine distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India respiratory medicines partner, offering high-quality sustained-release formulations for global healthcare supply.

Selective bronchodilator with improved safety compared to traditional xanthines
Sustained-release formulation for prolonged therapeutic action
Provides effective airway relaxation and improved breathing
Lower risk of cardiac and central nervous system side effects
Maintains consistent plasma concentration for stable efficacy
Suitable for long-term respiratory management
Manufactured under cGMP and ISO-certified quality standards

Management of bronchial asthma
Treatment of chronic obstructive pulmonary disease (COPD)
Relief from bronchospasm and airway obstruction
Support in chronic respiratory conditions requiring bronchodilation
Helps improve lung function and oxygen intake

Extended drug release ensures long-lasting effect
Reduced dosing frequency enhances patient compliance
Minimizes fluctuations in drug levels
Decreases risk of dose-related side effects
Provides consistent therapeutic response
Suitable for chronic and maintenance therapy

Doxofylline Sustained-Release Tablets

Doxofylline Sustained-Release Tablets